BODY ACTION PRODUCTS CLIMAX CONTROL GEL- benzocaine gel

BODY ACTION PRODUCTS Climax Control Gel by

Drug Labeling and Warnings

BODY ACTION PRODUCTS Climax Control Gel by is a Otc medication manufactured, distributed, or labeled by PRODUCT MAX GROUP INC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active Ingredient

Benzocaine 5%

Purpose

Male Genital Desensitizer

Uses

• Helps in the prevention of premature ejaculation.

Warnings

For external use only.

• Avoid contact with the eyes.
• Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor.
• If you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• Apply a small amount to head and shaft of penis before intercourse.
• Wash product off after intercourse.

Other Information

Do not use if safety seal under cap is broken or missing.

Inactive Ingredients

Cellulose Thickener, Methylparaben, PEG-8, Propylene Glycol, Propylparaben, Water.

Package Labeling:

INGREDIENTS AND APPEARANCE

BODY ACTION PRODUCTS CLIMAX CONTROL GEL 
benzocaine gel

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 70742-282
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5)	BENZOCAINE	50 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
METHYLPARABEN (UNII: A2I8C7HI9T)
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 70742-282-00	60 mL in 1 BOTTLE; Type 0: Not a Combination Product	04/29/2022

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M017	04/29/2022

Labeler - PRODUCT MAX GROUP INC (134893911)